Consolidated Balance Sheets - USD ($)		Sep. 30, 2019		Jun. 30, 2019
Current assets:
Cash and cash equivalents		$ 1,403,900,000		$ 1,949,200,000
Short-term marketable securities (B)		3,545,100,000	[1]	10,500,000
Accounts receivable, net of allowance for doubtful accounts of $59.3 and $54.9, respectively		2,490,400,000		2,439,300,000
Other current assets		675,900,000		509,100,000
Total current assets before funds held for clients		8,115,300,000		4,908,100,000
Funds held for clients		21,393,200,000		29,434,200,000
Total current assets		29,508,500,000		34,342,300,000
Long-term receivables, net of allowance for doubtful accounts of $0.6 and $0.4, respectively		22,100,000		23,800,000
Property, plant and equipment, net		767,100,000		764,200,000
Operating Lease, Right-of-Use Asset		504,000,000.0		0
Deferred contract costs		2,401,400,000		2,428,500,000
Other assets		1,129,400,000		934,400,000
Goodwill		2,303,300,000		2,323,000,000.0
Intangible assets, net		1,078,900,000		1,071,500,000
Total assets		37,714,700,000		41,887,700,000
Current liabilities:
Accounts payable		108,800,000		125,500,000
Accrued expenses and other current liabilities		1,994,600,000		1,759,000,000.0
Accrued payroll and payroll-related expenses		443,600,000		721,100,000
Dividends payable		339,100,000		340,100,000
Short-term deferred revenues		213,100,000		220,700,000
Obligations under reverse repurchase agreements (A)	[2]	428,600,000		262,000,000.0
Obligations under reverse repurchase agreements (A)		3,536,700,000	[1]	0
Short-term debt		1,001,300,000		0
Income taxes payable		123,700,000		54,800,000
Total current liabilities before client funds obligations		8,189,500,000		3,483,200,000
Client funds obligations		21,011,400,000		29,144,500,000
Total current liabilities		29,200,900,000		32,627,700,000
Long-term debt		1,003,400,000		2,002,200,000
Operating lease liabilities		355,400,000		0
Other liabilities		707,900,000		798,700,000
Deferred income taxes		708,200,000		659,900,000
Long-term deferred revenues		378,200,000		399,300,000
Total liabilities		32,354,000,000.0		36,487,800,000
Commitments and contingencies (Note 13)
Stockholders' equity:
Preferred stock, $1.00 par value: authorized, 0.3 shares; issued, none		0		0
Common stock, $0.10 par value: authorized, 1,000.0 shares; issued, 638.7 shares at September 30, 2019 and June 30, 2019; outstanding, 433.4 and 434.2 shares at September 30, 2019 and June 30, 2019, respectively		63,900,000		63,900,000
Capital in excess of par value		1,213,700,000		1,183,200,000
Retained earnings		17,729,600,000		17,500,600,000
Treasury stock - at cost: 205.3 and 204.5 shares at September 30, 2019 and June 30, 2019, respectively		(13,412,600,000)		(13,090,500,000)
Accumulated other comprehensive loss		(233,900,000)		(257,300,000)
Total stockholders’ equity		5,360,700,000		5,399,900,000
Total liabilities and stockholders’ equity		37,714,700,000		41,887,700,000
Long-term Marketable Securities Under Reverse Repurchase Agreements		428,000,000.0		261,400,000
Cash And Cash Equivalents Under Reverse Repurchase Agreements		600,000		$ 600,000
Short-term Marketable Securities under Commercial Paper borrowings		$ 3,535,500,000

[1] (B) The Company reclassified $3,535.5 million of funds held for clients to short-term marketable securities as a result of proceeds from commercial paper borrowings as of September 30, 2019 which were utilized to pay our client obligations.

[2] (A) As of September 30, 2019, $428.0 million of long-term marketable securities and $0.6 million of cash and cash equivalents have been pledged as collateral under the Company's reverse repurchase agreements. As of June 30, 2019, $261.4 million of long-term marketable securities and $0.6 million of cash and cash equivalents have been pledged as collateral under the Company's reverse repurchase agreements. Refer to Note 9